STOCK TITAN

AUTOLUS THERAPEUTICS PLC (AUTL) Net Income by Year

AUTL

AUTOLUS THERAPEUTICS PLC reported a net loss of $287.5M in fiscal year 2025. This represents a decrease of 30.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $280.2M net loss. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters AUTOLUS THERAPEUTICS PLC has filed alongside them.

FY2025 annual
Net Income -$287.5M
YoY -30.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

AUTL Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Net Income-$280.2M-$287.5M-30.3%-$220.7M-5.9%-$208.4M-40.0%-$148.8M-4.7%-$142.1M0.0%-$142.1M-14.7%-$123.8M-176.8%-$44.8M-126.9%-$19.7M-57.2%-$12.6M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

AUTL Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$39.1M+18.4%-$71.6M-2.0%-$90.3M-$79.1M+3.6%-$47.9M+17.8%-$70.2M-33.2%N/A-$82.1M-79.1%-$58.3M-27.9%-$52.7M-32.4%N/A-$45.8M-7.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More AUTOLUS THERAPEUTICS PLC financials

Frequently Asked Questions

What was AUTOLUS THERAPEUTICS PLC's net income in fiscal year 2025?

AUTOLUS THERAPEUTICS PLC reported a net loss of $287.5M in fiscal year 2025.

How fast is AUTOLUS THERAPEUTICS PLC's net income growing?

AUTOLUS THERAPEUTICS PLC (AUTL) net income fell by 30.3% year over year, from -$220.7M to -$287.5M in fiscal year 2025.

What is AUTOLUS THERAPEUTICS PLC's net income over the last twelve months?

AUTOLUS THERAPEUTICS PLC (AUTL) reported a $280.2M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 10 fiscal years this page covers, AUTOLUS THERAPEUTICS PLC (AUTL) net income went from -$12.6M in fiscal year 2016 to -$287.5M in fiscal year 2025.

AUTOLUS THERAPEUTICS PLC (AUTL) reported -$39.1M in net income in Q2 2026. This represents an increase of 18.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what AUTOLUS THERAPEUTICS PLC (AUTL) reported on that line in every period on record.